Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marsha Hauger"'
Autor:
Charles L. Shapiro, Bhuvaneswari Ramaswamy, Kari Kendra, Miguel A. Villalona-Calero, Marsha Hauger, Tim Moore, Ewa Mrozek, Padma Nadella, Chris A. Rhoades, Nancy J. Merriman, Holly Watson, Donn C. Young, Joan Allen
Publikováno v:
Clinical Breast Cancer. 7:141-145
Purpose This phase II study evaluated the safety and efficacy of weekly docetaxel and capecitabine in patients with metastatic breast cancer. Patients and Methods Thirty-nine patients with metastatic breast cancer received 30 mg/m 2 of docetaxel on d
Autor:
Anthony D. Elias, Bhuvaneswari Ramaswamy, Angela Dodley, Mark Morrow, Charles L. Shapiro, Nicole T. Kelbick, Chris A. Rhoades, Kari Kendra, S. Gail Eckhardt, Marsha Hauger, Helen X. Chen, Joan Allen
Publikováno v:
Clinical Cancer Research. 12:3124-3129
Purpose: To evaluate the safety and efficacy of bevacizumab and weekly docetaxel as first- or second-line therapy in patients with metastatic breast cancer (MBC).Patients and Methods: Twenty-seven MBC patients received i.v. bevacizumab at 10 mg/kg on
Publikováno v:
Regulatory Peptides. 109:189-192
Several neuropeptides are secreted in high amounts in pediatric tumors such as neuroblastoma and have been used as markers of residual or recurrent disease. Plasma levels of neuropeptides might be expected to change during development, but have not b
Autor:
Eric H. Kraut, Steven K. Clinton, Paul Monk, Marsha Hauger, Padma Nadella, Gregory A. Otterson, Selnur Erdal, Manisha H. Shah, Mike Stanek, Miguel A. Villalona-Calero, Charles L. Shapiro
Publikováno v:
Journal of Clinical Oncology. 20:2616-2623
PURPOSE: Capecitabine and docetaxel have demonstrated preclinical antitumor synergy. This synergy is thought to occur from docetaxel-mediated upregulation of thymidine phosphorylase (dThdPase), an enzyme responsible for the relative tumor selectivity
Autor:
William B. Farrar, Joan Allen, Kari Kendra, William E. Burak, Steven P. Povoski, Robert Z. Orlowski, S Somasundaram, Marsha Hauger, Lisa D. Yee, Charles L. Shapiro, Donn C. Young, Chris A. Rhoades, Bhuvaneswari Ramaswamy
Publikováno v:
Breast cancer research and treatment. 93(1)
Purpose. In most neoadjuvant chemotherapy regimens, the taxane is administered either in combination with an anthracycline or after an anthracycline-containing regimen. We sought to test the feasibility, safety, and determine the pathological complet